These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19878317)

  • 1. In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods.
    Guo N; Wu X; Yu L; Liu J; Meng R; Jin J; Lu H; Wang X; Yan S; Deng X
    FEMS Immunol Med Microbiol; 2010 Mar; 58(2):193-201. PubMed ID: 19878317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans.
    Guo N; Ling G; Liang X; Jin J; Fan J; Qiu J; Song Y; Huang N; Wu X; Wang X; Deng X; Deng X; Yu L
    Mycoses; 2011 Sep; 54(5):e400-6. PubMed ID: 21910756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
    Jin J; Guo N; Zhang J; Ding Y; Tang X; Liang J; Li L; Deng X; Yu L
    Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents.
    Shi W; Chen Z; Chen X; Cao L; Liu P; Sun S
    FEMS Yeast Res; 2010 Nov; 10(7):885-93. PubMed ID: 20707818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model.
    Khodavandi A; Alizadeh F; Harmal NS; Sidik SM; Othman F; Sekawi Z; Jahromi MA; Ng KP; Chong PP
    FEMS Microbiol Lett; 2011 Feb; 315(2):87-93. PubMed ID: 21204918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal activity of thymol against clinical isolates of fluconazole-sensitive and -resistant Candida albicans.
    Guo N; Liu J; Wu X; Bi X; Meng R; Wang X; Xiang H; Deng X; Yu L
    J Med Microbiol; 2009 Aug; 58(Pt 8):1074-1079. PubMed ID: 19528168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves.
    Li Y; Sun S; Guo Q; Ma L; Shi C; Su L; Li H
    J Antimicrob Chemother; 2008 Mar; 61(3):577-85. PubMed ID: 18194958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
    Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY
    Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans.
    Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H
    FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
    Yücesoy M; Marol S
    Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antifungal activity of the berberine and its synergism with fluconazole.
    Iwazaki RS; Endo EH; Ueda-Nakamura T; Nakamura CV; Garcia LB; Filho BP
    Antonie Van Leeuwenhoek; 2010 Feb; 97(2):201-5. PubMed ID: 19882381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
    Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
    FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans.
    An M; Shen H; Cao Y; Zhang J; Cai Y; Wang R; Jiang Y
    Int J Antimicrob Agents; 2009 Mar; 33(3):258-63. PubMed ID: 19095412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro activity of fluconazole against Candida albicans isolated from blood culture].
    Pemán J; Cantón E; Orero A; Ubeda P; Viudes A; Pastor A; Gobernado M
    Rev Esp Quimioter; 1998 Dec; 11(4):339-43. PubMed ID: 10336314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata.
    Dovigo LN; Pavarina AC; Mima EG; Giampaolo ET; Vergani CE; Bagnato VS
    Mycoses; 2011 Mar; 54(2):123-30. PubMed ID: 19889173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans.
    Bulatova NR; Darwish RM
    Med Princ Pract; 2008; 17(2):117-21. PubMed ID: 18287794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
    Xu Y; Chen L; Li C
    J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.